Drug use management in board and care facilities

Gerontologist

Volumn 37, Issue 6, 1997, Pages 748-756

  Garrard, Judith ^a   Cooper, Susan L ^b   Goertz, Christine ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b REGIONS HOSPITAL   (United States)

^c American Chiropractic Association   (United States)

Author keywords

Board and care facilities; Long term care; Medication management; Psychotropic drugs

Indexed keywords

ARTICLE; HEALTH CARE POLICY; LONG TERM CARE; MEDICAL RECORD; MENTAL HEALTH CENTER; MENTAL HEALTH SERVICE; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; TREATMENT PLANNING;

EID: 0031458036     PISSN: 00169013     EISSN: None     Source Type: Journal    
DOI: 10.1093/geront/37.6.748     Document Type: Article

References (14)

1. Avorn, J., Dreyer, P., Connely, K., & Soumerai, S. B. (1989). Use of psychoactive medication and the quality of care in rest homes. New England Journal of Medicine, 320(4), 227-232.
2. Dillman, D. A. (1978). Mail and telephone surveys: The total design method. New York: Wiley.
3. Garrard, J., Chen, V., & Dowd, B. (1995). Impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes. American Journal of Public Health, 85(6), 771-776.
4. Garrard, J., Nitz, N. M., & Rolnick, S. J. (1996). Preliminary results of psychotropic drugs used by community based elderly people. Unpublished report. Minneapolis, MN: Institute for Health Services Research, University of Minnesota.
5. Health Care Financing Administration. (1989). Medicare and Medicaid: Requirements for long term care facilities; final rule with request for comments. Federal Register (February 2); 54(21), 5333-5336.
6. Jonas, S. (1986). Health care delivery in the United States (3rd ed.). New York: Springer.
7. Lux, L., Hawes, C., Wildfire, J., Mor, V., & LaLiberte, L. (November, 1992). Board and care regulations: A comparative analysis of state regulations. Paper presented at the annual meeting of the Gerontological Society of America, Washington, DC.
8. Perfetto, E. M. (1992). Variations in physician drug prescribing for a rest home population (Dissertation). Chapel Hill: University of North Carolina.
9. Select Committee on Aging, Subcommittee on Health and Long-Term Care. U.S. House of Representatives (1989). Board and care homes in America: A national tragedy (Committee Publ. No. 101-711, March). Washington, DC: U.S. Government Printing Office.
10. Select Committee on Aging, Subcommittee on Health and Long-Term Care. U.S. House of Representatives. (1992). Drug abuse and misuse in America's board and care homes: Failure in public policy (Committee Publ. No. 102-856, March). Washington, DC: U.S. Government Printing Office.
11. Spore, D., Mor, V., Larrat, E. P., Hiris, J., & Hawes, C. (1996). Regulatory environment and psychotropic use in board-and-care facilities: Results of a 10-state study. Journal of Gerontology: Medical Sciences, 51A, M131-M141.
12. U.S. General Accounting Office. (1989). Board and care: Insufficient assurances that residents' needs are identified and met (Report to Congressional Requesters. GAO/HRD-89-50). Gaithersburg, MD: Author.
13. U.S. General Accounting Office. (1992). Board and care homes: Elderly at risk from mishandled medications. (Report to the Chairman, Subcommittee on Health and Long-Term Care, Select Committee on Aging, House of Representatives. GAO/HRD-92-45). Gaithersburg, MD: Author.
14. Wildfire, J., Hawes, C., & Lux, L. (November, 1992). Unlicensed board and care homes: A method of locating them. Paper presented at the Annual Meeting of the Gerontological Society of America, Washington, DC.